Australia markets open in 8 hours 24 minutes

Haemonetics Corporation (HAE)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
88.09-0.76 (-0.86%)
As of 11:34AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2024
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Total revenue
1,309,055
1,309,055
1,168,660
993,196
870,463
-
Cost of revenue
617,507
617,507
553,563
487,694
472,625
-
Gross profit
691,548
691,548
615,097
505,502
397,838
-
Operating expenses
Research development
54,435
54,435
50,131
46,801
32,857
-
Selling general and administrative
431,780
431,780
376,675
340,140
275,216
-
Total operating expenses
518,246
518,246
459,446
434,355
340,903
-
Operating income or loss
173,302
173,302
155,651
71,147
56,935
-
Interest expense
13,018
13,018
14,630
17,121
16,834
-
Total other income/expenses net
-8,419
-8,419
382
9,603
32,812
-
Income before tax
151,865
151,865
141,403
63,629
72,913
-
Income tax expense
34,307
34,307
26,002
20,254
-6,556
-
Income from continuing operations
117,558
117,558
115,401
43,375
79,469
-
Net income
117,558
117,558
115,401
43,375
79,469
-
Net income available to common shareholders
117,558
117,558
115,401
43,375
79,469
-
Basic EPS
2.53
-
2.27
0.85
1.57
1.51
Diluted EPS
2.49
-
2.24
0.84
1.55
1.48
Basic average shares
50,556
-
50,783
51,047
50,688
50,692
Diluted average shares
51,294
-
51,420
51,353
51,292
51,815